- Home
- SNSE vs GNLN Comparison
SNSE vs GNLN Comparison
Compare SNSE & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNSE | GNLN |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Durable Goods |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 12.9M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SNSE | GNLN |
|---|---|---|
| Price | $10.80 | $1.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $72.50 | N/A |
| AVG Volume (30 Days) | 74.5K | ★ 128.6K |
| Earning Date | 11-14-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,653,000.00 |
| Revenue This Year | N/A | $1,541.21 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.00 | $1.50 |
| 52 Week High | $18.35 | $1,342.53 |
Technical Indicators
Market Signals| Indicator | SNSE | GNLN |
|---|---|---|
| Relative Strength Index (RSI) | 61.97 | 21.66 |
| Support Level | $8.37 | $1.50 |
| Resistance Level | $11.45 | $1.77 |
| Average True Range (ATR) | 0.99 | 0.24 |
| MACD | 0.24 | -0.07 |
| Stochastic Oscillator | 87.94 | 3.26 |
Price Performance
Historical ComparisonAbout SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.